Diseases, Conditions, Syndromes

COVID-19 antibody 'cocktail' protects chronically ill: study

A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults ...

Diseases, Conditions, Syndromes

US hoping for two COVID-19 vaccines by end of November

Two American companies expect to apply for emergency approval for their COVID-19 vaccines by late November, welcome news as the US crossed eight million confirmed cases amid a third surge of its coronavirus epidemic.

Diseases, Conditions, Syndromes

Blow to global vaccine drive as Pfizer delays deliveries

A global coronavirus vaccine rollout suffered a major blow Friday as Pfizer said it would delay shipments of the jabs in the next three to four weeks due to works at its key plant in Belgium.

page 6 from 40